文献速递肾小球疾病

TLR9激活通过APRIL和IL-6介导的途径诱导IgA肾病中异常IgA糖基化

TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
PubMed 文献 · Kidney Int · 2019-09-05

本研究探讨TLR9激活如何导致IgA肾病中致病性IgA的产生。在ddY小鼠和人类IgA1分泌细胞中,TLR9配体CpG寡核苷酸增加异常糖基化IgA和IgG-IgA免疫复合物,加重肾损伤;TLR9激活上调APRIL和IL-6,两者独立且协同促进半乳糖缺陷型IgA1(Gd-IgA1)的过度产生。

要点

  • TLR9激活可诱导IgA肾病中Gd-IgA1的过度产生。
  • APRIL和IL-6介导TLR9诱导的Gd-IgA1合成,且两者独立又协同。
  • TLR9激活加重ddY小鼠肾损伤,与异常糖基化IgA和免疫复合物升高相关。

核心结论

  • TLR9激活增强异常糖基化IgA的合成,并在IgA肾病小鼠模型中加重肾损伤。
  • APRIL和IL-6协同且独立地增强Gd-IgA1的合成。

研究设计与样本

  • 研究在IgA肾病倾向ddY小鼠和人类IgA1分泌细胞中进行。
  • 使用TLR9配体CpG寡核苷酸刺激,并采用siRNA敲低和中和抗体实验。

主要发现

  • 注射CpG寡核苷酸增加ddY小鼠异常糖基化IgA和IgG-IgA免疫复合物的产生,并加重肾损伤。
  • CpG寡核苷酸刺激的小鼠血清APRIL水平升高,且与异常糖基化IgA和IgG-IgA免疫复合物水平相关。
  • 体外TLR9激活增强ddY小鼠脾细胞和人类IgA1分泌细胞中致病性IgA以及APRIL和IL-6的产生。
  • siRNA敲低APRIL完全抑制IL-6诱导的Gd-IgA1过度产生;中和IL-6减少CpG寡核苷酸诱导的Gd-IgA1过度产生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Galactose-deficient IgA1 (Gd-IgA1) plays a crucial role in the development of IgA nephropathy (IgAN). However, the pathogenic mechanisms driving Gd-IgA1 production have not been fully elucidated. Innate-immune activation via Toll-like receptor 9 (TLR9) is known to be involved in Gd-IgA1 production. A proliferation inducing ligand (APRIL) and IL-6 are also known to enhance Gd-IgA1 synthesis in IgAN. With this as background, we investigated how TLR9 activation in IgA secreting cells results in overproduction of nephritogenic IgA in the IgAN-prone ddY mouse and in human IgA1-secreting cells. Injection of the TLR9 ligand CpG-oligonucleotides increased production of aberrantly glycosylated IgA and IgG-IgA immune complexes in ddY mice that, in turn, exacerbated kidney injury. CpG-oligonucleotide-stimulated mice had elevated serum levels of APRIL that correlated with those of aberrantly glycosylated IgA and IgG-IgA immune complexes. In vitro, TLR9 activation enhanced production of the nephritogenic IgA as well as APRIL and IL-6 in splenocytes of ddY mice and in human IgA1-secreting cells. However, siRNA knock-down of APRIL completely suppressed overproduction of Gd-IgA1 induced by IL-6. Neutralization of IL-6 decreased CpG-oligonucleotide-induced overproduction of Gd-IgA1. Furthermore, APRIL and IL-6 pathways each independently mediated TLR9-induced overproduction of Gd-IgA1. Thus, TLR9 activation enhanced synthesis of aberrantly glycosylated IgA that, in a mouse model of IgAN, further enhanced kidney injury. Hence, APRIL and IL-6 synergistically, as well as independently, enhance synthesis of Gd-IgA1.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Makita Y, Suzuki H, Kano T, et al. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy. Kidney Int. 2019. PMID: 31748116. doi:10.1016/j.kint.2019.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。